drugset / Trial / NCT06077019

Role of Lung Function for Exercise Capacity in Well-trained Individuals

NCT06077019

Recruiting 60 enrolled Morten Hostrup, PhD
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of the project is to investigate exercise performance in humans following prolonged inhalation of beta2-agonists vilanterol + fluticasone furoate or indacaterol + mometasone furoate

Timeline

Start
2023-10-03
Primary completion
2026-07-15
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Furoate Other / unclassified Inhaled
Subject Indacaterol Other / unclassified 125 ug Inhaled
Subject Mometasone furoate Other / unclassified Inhaled
Subject Vilanterol Other / unclassified 25 ug Inhaled

Indications

No indication recorded.